| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1.5 | 2.3 |
| Gross profit | 0.3 | 1.1 |
| Profit before tax | -2.8 | -0.0 |
| Net income | -2.8 | -0.3 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -35.5% |
|---|---|
| Gross margin | 20.8% |
| Operating margin | -145.0% |
10-Q filed with the SEC, OTC: VSEE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Vsee Health, Inc.: key numbers
- Share price
- $0.2900Close, Nov 16
- Market cap
- $254K
- Shares outstanding
- 876.84KLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Health ServicesSIC 8000
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Vsee Health, Inc.
All →Vsee Health Debt Financing Update with Vanquish
VSee Health issued an additional unsecured convertible promissory note to Vanquish in the principal amount of $180,550, which includes an original issue discount. The note carries a one-time 12% interest charge and is convertible into common stock only upon an event of default at a 35% discount to the market price.
- Counterparty
- Vanquish
- Term
- through July 30, 2027
Vsee Health Reverse Stock Split
VSee Health, Inc. has filed a Certificate of Amendment to effect a 1-for-80 reverse stock split of its common stock, effective September 23, 2026. The stock will begin trading on a split-adjusted basis on September 24, 2026, under a new CUSIP number. No fractional shares will be issued, with any resulting fractions rounded up to the next whole number.